Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intestinal endometrosis mimicking Crohn's disease: a rare cause of nonspecific abdominal pain.

Endokrynologia Polska·2026
Same author

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

The lancet. Diabetes & endocrinology·2026
Same author

The application of artificial intelligence in adrenal imaging: current state of knowledge, challenges, and future directions.

Endocrine connections·2026
Same author

ERS Statement on ultrasound guided interventions in respiratory disease.

The European respiratory journal·2026
Same author

Phosphate handling as a determinant of osteoporosis in primary hyperparathyroidism.

Endocrine connections·2026
Same author

Muscle pain in a woman with congenital adrenal hyperplasia due to 21-hydroxylase deficiency resolved with testosterone therapy. A case report with 10 years of follow-up.

Frontiers in endocrinology·2026

Related Experiment Videos

Amiodarone induced pneumonitis and hyperthyroidism: case report.

Elzbieta Magdalena Grabczak1, Tadeusz M Zielonka, Joanna Wiwała

  • 1Chair and Department of internal Diseases, Pneumonology and Allergology, Warsaw Medical University, Warszawa, Poland. mgrabczak@yahoo.com

Polskie Archiwum Medycyny Wewnetrznej
|October 14, 2008
PubMed
Summary

Amiodarone, an antiarrhythmic drug, can cause serious side effects like hyperthyroidism and lung issues, even with short-term use. Careful patient selection and monitoring are crucial for safe amiodarone therapy.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Pulmonology
  • Endocrinology

Background:

  • Amiodarone is a vital antiarrhythmic medication for managing severe arrhythmias.
  • Long-term amiodarone use is associated with numerous potential adverse effects.
  • Adverse effects can manifest in various organ systems, including the eyes, liver, thyroid, lungs, bone marrow, skin, and nervous system.

Observation:

  • A case study details a 56-year-old man experiencing amiodarone-induced hyperthyroidism and interstitial pulmonary lesions after short-term therapy for atrial fibrillation.
  • Symptoms of hyperthyroidism and pulmonary involvement appeared weeks after discontinuing amiodarone.
  • Standard treatments, including antibiotics, thiamazole, and propranolol, were initially ineffective.

Findings:

  • The patient's condition improved only after combination therapy with thiamazole and glucocorticosteroids.
  • This case highlights the risk of two severe, concurrent adverse effects from short-term amiodarone exposure.
  • Differential diagnoses for hyperthyroidism and pulmonary lesions did not reveal alternative pathologies.

Implications:

  • Emphasizes the importance of judicious patient selection for amiodarone therapy.
  • Underscores the necessity of vigilant monitoring for adverse effects during and after amiodarone treatment.
  • Suggests that even short-term amiodarone use warrants careful consideration of potential serious side effects.